AMVUTTRA is a Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Alnylam Pharmaceuticals, Inc.. The primary component is Vutrisiran.
| Product ID | 71336-1003_5cff1285-ac61-47d7-a8e5-98fb52d44b27 |
| NDC | 71336-1003 |
| Product Type | Human Prescription Drug |
| Proprietary Name | AMVUTTRA |
| Generic Name | Vutrisiran |
| Dosage Form | Injection |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2022-06-13 |
| Marketing Category | NDA / |
| Application Number | NDA215515 |
| Labeler Name | Alnylam Pharmaceuticals, Inc. |
| Substance Name | VUTRISIRAN |
| Active Ingredient Strength | 25 mg/.5mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-06-13 |
| NDC Exclude Flag | N |
| Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() AMVUTTRA 97057480 not registered Live/Pending |
Alnylam Pharmaceuticals, Inc. 2021-10-03 |
![]() AMVUTTRA 97057473 not registered Live/Pending |
Alnylam Pharmaceuticals, Inc. 2021-10-03 |
![]() AMVUTTRA 90151672 not registered Live/Pending |
Alnylam Pharmaceuticals, Inc. 2020-09-01 |